H. Michael Rodriguez Email and Phone Number

As the Vaccines Therapeutic Area Lead within Portfolio and Decision Analysis at Pfizer, I lead cross-functional strategic initiatives to maximize the value of our R&D investments. A significant aspect of my role involves financial modeling and building investment proposals, having directly contributed to executive leadership securing over $3.5 billion from Pfizer’s investment committee. This funding supports a portfolio poised to generate over $20 billion in potential future annual revenues, with key R&D assets such as COMIRNATY, PREVNAR 20, ABRYSVO, and PENBRAYA launched during my tenure.Beyond clinical data and market research, my portfolio strategy and asset valuation expertise form the foundation for critical investment decisions, significantly enhancing our prioritization frameworks and optimizing at-risk investments. Challenging medicine teams to think innovatively when designing clinical trials and refining our approach to evaluating opportunities, I ensure our strategic decisions are grounded in rigorous analysis and aligned with Pfizer's mission.I'm pursuing an MBA at Columbia Business School to deepen my expertise in healthcare innovation and transactions within venture capital and private equity to enhance my ability to make impactful capital allocation decisions.